$MRK Recent Headlines
Safe and steady ETFs for the new year 12:03 p.m. Dec. 9, 2013 - Jim Lowell
Merck, McDonald's are top decliners in Dow index 4:05 p.m. Dec. 4, 2013 - Polya Lesova
Cuts, stock buyback, acquisition combine to boost Forest shares 11:09 a.m. Dec. 2, 2013 - blogs.marketwatch.com
Merck, J.P. Morgan lead Dow decliners 9:35 a.m. Nov. 13, 2013 - Laura Mandaro
Merck, Cisco lead gainers in Dow industrials 4:03 p.m. Nov. 12, 2013 - Polya Lesova
Bitcoin buying for dummies 3:22 p.m. Nov. 12, 2013 - blogs.marketwatch.com
Planned layoffs up 13.5% in October: Challenger 7:30 a.m. Nov. 6, 2013 - Steve Goldstein
Newscast: S&P 500 notches year's 32nd record high 8:08 p.m. Oct. 28, 2013 - MarketWatch
J.C. Penney, Bristol-Myers top S&P 500 7:08 p.m. Oct. 28, 2013 - Saumya Vaishampayan
S&P up for 8th day in 9; Dow, Nasdaq flat 4:57 p.m. Oct. 28, 2013 - Victor Reklaitis
Newscast: Stocks mixed after lackluster day 4:26 p.m. Oct. 28, 2013 - MarketWatch
Newscast: Car reliability ranks get new members 2:28 p.m. Oct. 28, 2013 - MarketWatch
Merck shares stumble on earnings weakness, talk of divesting assets 10:58 a.m. Oct. 28, 2013 - blogs.marketwatch.com
Merck, down 2.2%, leads Dow average lower 9:34 a.m. Oct. 28, 2013 - Laura Mandaro
Stock futures continue to waver after data 9:30 a.m. Oct. 28, 2013 - Sara Sjolin
Apple is Monday’s stock to watch as results loom 8:21 a.m. Oct. 28, 2013 - Sue Chang
Merck profit down 35% as Singulair sales fall 7:25 a.m. Oct. 28, 2013 - MarketWatch.com
Merck third-quarter profit, revenue fall 7:17 a.m. Oct. 28, 2013 - Saumya Vaishampayan
Merck narrows 2013 EPS guidance; holds sales view 7:10 a.m. Oct. 28, 2013 - Saumya Vaishampayan
Merck Q3 adj. EPS edges down to $0.92 vs. $0.95 7:03 a.m. Oct. 28, 2013 - Saumya Vaishampayan
Merck (MRK) Weak In Early Morning Trading 8:45 a.m. Today - TheStreet.com
Novartis mulls swapping animal-health ops with another business 7:16 a.m. Today - Seeking Alpha
Wall Street Breakfast: Must-Know News 6:33 a.m. Today - Seeking Alpha
Merck Says Data Monitoring Committee Recommending Continuation of Phase II/III EPOCH Study for MK-8931 6:10 a.m. Today - benzinga.com
4 Companies Developing Blockbuster Immunotherapies To Fight Cancer 12:03 p.m. Dec. 9, 2013 - Seeking Alpha
A Blizzard of Dividend Cash Coming 11:00 a.m. Dec. 9, 2013 - RealMoney.com
Buy Today: Merck & Co Inc's Buy Recommendation Reiterated 9:05 a.m. Dec. 9, 2013 - TheStreet.com
The Numbers Backing Gilead's Best and Fastest Drug Launch in History 6:31 a.m. Dec. 9, 2013 - TheStreet.com
Merck Serono Announces New Publication of Results of the Phase III START Trial Investigating Tecemotide in Non-Small Cell Lung Cancer in The Lancet Oncology 5:35 a.m. Dec. 9, 2013 - CNW Group
Update on Hospira's Investor Day - Analyst Blog 6:10 p.m. Dec. 6, 2013 - Zacks.com
Gilead Potential Blockbuster Hep C Drug Wins FDA Nod 4:22 p.m. Dec. 6, 2013 - Investors Business Daily
Pfizer - Key Reasons to Long This Biopharmaceutical Giant 3:56 p.m. Dec. 6, 2013 - GuruFocus.com
Strong Employment And Consumer Data Are Changing The Game On Wall Street 1:22 p.m. Dec. 6, 2013 - Seeking Alpha
Today's Stocks Driving Success For The Health Care Sector 12:03 p.m. Dec. 6, 2013 - TheStreet.com
4 Potential Blockbuster Drugs Awaiting Launch 5:21 p.m. Dec. 5, 2013 - Investors Business Daily
Merck & Co Inc (MRK): Today's Featured Drugs Laggard 5:03 p.m. Dec. 5, 2013 - TheStreet.com
The Deal: Merck Stakes $3 Billion on Gadget Growth 4:01 p.m. Dec. 5, 2013 - TheStreet.com
Forest Laboratories: Merck's Saphris Acquisition Is A Good Move 1:15 p.m. Dec. 5, 2013 - Seeking Alpha
The Future of Diabetes Control: Treat the Cause, Not the Symptom 9:59 a.m. Dec. 5, 2013 - Wall St. Cheat Sheet
Pharma & Biotech Stock Outlook - Dec 2013 - Industry Outlook 4:28 a.m. Dec. 3, 2013 - Zacks.com
ALK announces posting of briefing documents for FDA Advisory Committee meeting on the grass sublingual AIT tablet 8:22 a.m. Today - GlobeNewswire
Merck Advances Development Program for Investigational Alzheimer's Disease Therapy, MK-8931 7:00 a.m. Today - BusinessWire
Exostar-Powered Identity & Access Management Platform Named North America Health Care Project of the Year 9:09 a.m. Dec. 5, 2013 - BusinessWire
The Approval Of The First Biosimilar Monoclonal Antibody In Europe Has Major Implications For 2014 And Beyond 8:00 a.m. Dec. 5, 2013 - PR Newswire
Increased Quarterly Dividends, HIV Elimination Efforts, Advanced Treatment Options, and Conference Participations - Research Report on Merck, Varian, Mylan, Achillion, and Abiomed 8:00 a.m. Dec. 4, 2013 - PR Newswire
Intarcia Therapeutics Appoints Nancy Thornberry to Board of Directors 2:37 p.m. Dec. 2, 2013 - PR Newswire
Forest to Acquire U.S. Marketing Rights to Saphris(R) (asenapine) from Merck 9:00 a.m. Dec. 2, 2013 - BusinessWire
EMD Serono's New Spin-off TocopheRx to Focus on Infertility Treatment 8:30 a.m. Dec. 2, 2013 - BusinessWire
FDA Approvals, Stock Price Updates, New Study Results, Conference Schedules and Partnerships - Research Report on Merck, Pharmacyclics, UnitedHealth Group, Medtronic, and AstraZeneca 8:00 a.m. Nov. 29, 2013 - PR Newswire
Merck Announces Increased Quarterly Dividend 2:18 p.m. Nov. 26, 2013 - BusinessWire
FDA Approves Merck's NOXAFIL(R) (posaconazole) Delayed-Release Tablets 9:00 a.m. Nov. 26, 2013 - BusinessWire
Stock Price Movements and Program Launches Reported by Healthcare Companies - Research Report on Merck, Abiomed, Alere, Raptor Pharmaceuticals and West Pharmaceutical Services 8:00 a.m. Nov. 26, 2013 - PR Newswire
SiSense Wins Quarter Million Dollar Prize, Takes Top Honor in "Take the H.E.L.M." Competition 11:30 a.m. Nov. 25, 2013 - PR Newswire
Mondo Guerra and the Merck HIV Educational Campaign I Design Invite the Community to Pledge Action in Honor of World AIDS Day 8:01 a.m. Nov. 25, 2013 - PR Newswire
ARMO BioSciences Initiates Phase 1 Clinical Trial of First-In-Class Cancer Immunotherapy 8:00 a.m. Nov. 25, 2013 - PR Newswire
European Patent Office Issues Decision Regarding Universal Display's Organometallic Iridium Patent 9:01 a.m. Nov. 22, 2013 - BusinessWire
Sixth Annual Biotech Showcase(TM) Returns to San Francisco January 13-15 6:51 p.m. Nov. 21, 2013 - BusinessWire
FDA Approvals, Stock Price Movements, and Study Results - Research Report on Pfizer, Celgene, Merck, Quest Diagnostics, and Pharmacyclics 8:00 a.m. Nov. 21, 2013 - PR Newswire
Merck Consumer Health Turnaround on Track 4:00 a.m. Nov. 21, 2013 - BusinessWire
Critical Alerts For Netflix, Salesforce.com, Goldman Sachs, Merck, and Valero Energy Released By InvestorsObserver 9:31 a.m. Nov. 19, 2013 - PR Newswire
Safe and steady ETFs for the new year 12:03 p.m. Dec. 9, 2013 - Jim Lowell
Merck, McDonald's are top decliners in Dow index 4:05 p.m. Dec. 4, 2013 - Polya Lesova
Cuts, stock buyback, acquisition combine to boost Forest shares 11:09 a.m. Dec. 2, 2013 - blogs.marketwatch.com
Merck, J.P. Morgan lead Dow decliners 9:35 a.m. Nov. 13, 2013 - Laura Mandaro
Merck, Cisco lead gainers in Dow industrials 4:03 p.m. Nov. 12, 2013 - Polya Lesova
Bitcoin buying for dummies 3:22 p.m. Nov. 12, 2013 - blogs.marketwatch.com
Planned layoffs up 13.5% in October: Challenger 7:30 a.m. Nov. 6, 2013 - Steve Goldstein
Newscast: S&P 500 notches year's 32nd record high 8:08 p.m. Oct. 28, 2013 - MarketWatch
J.C. Penney, Bristol-Myers top S&P 500 7:08 p.m. Oct. 28, 2013 - Saumya Vaishampayan
S&P up for 8th day in 9; Dow, Nasdaq flat 4:57 p.m. Oct. 28, 2013 - Victor Reklaitis
Newscast: Stocks mixed after lackluster day 4:26 p.m. Oct. 28, 2013 - MarketWatch
Newscast: Car reliability ranks get new members 2:28 p.m. Oct. 28, 2013 - MarketWatch
Merck shares stumble on earnings weakness, talk of divesting assets 10:58 a.m. Oct. 28, 2013 - blogs.marketwatch.com
Merck, down 2.2%, leads Dow average lower 9:34 a.m. Oct. 28, 2013 - Laura Mandaro
Stock futures continue to waver after data 9:30 a.m. Oct. 28, 2013 - Sara Sjolin
Apple is Monday’s stock to watch as results loom 8:21 a.m. Oct. 28, 2013 - Sue Chang
Merck profit down 35% as Singulair sales fall 7:25 a.m. Oct. 28, 2013 - MarketWatch.com
Merck third-quarter profit, revenue fall 7:17 a.m. Oct. 28, 2013 - Saumya Vaishampayan
Merck narrows 2013 EPS guidance; holds sales view 7:10 a.m. Oct. 28, 2013 - Saumya Vaishampayan
Merck Q3 adj. EPS edges down to $0.92 vs. $0.95 7:03 a.m. Oct. 28, 2013 - Saumya Vaishampayan
Merck (MRK) Weak In Early Morning Trading 8:45 a.m. Today - TheStreet.com
Novartis mulls swapping animal-health ops with another business 7:16 a.m. Today - Seeking Alpha
Wall Street Breakfast: Must-Know News 6:33 a.m. Today - Seeking Alpha
Merck Says Data Monitoring Committee Recommending Continuation of Phase II/III EPOCH Study for MK-8931 6:10 a.m. Today - benzinga.com
4 Companies Developing Blockbuster Immunotherapies To Fight Cancer 12:03 p.m. Dec. 9, 2013 - Seeking Alpha
A Blizzard of Dividend Cash Coming 11:00 a.m. Dec. 9, 2013 - RealMoney.com
Buy Today: Merck & Co Inc's Buy Recommendation Reiterated 9:05 a.m. Dec. 9, 2013 - TheStreet.com
The Numbers Backing Gilead's Best and Fastest Drug Launch in History 6:31 a.m. Dec. 9, 2013 - TheStreet.com
Merck Serono Announces New Publication of Results of the Phase III START Trial Investigating Tecemotide in Non-Small Cell Lung Cancer in The Lancet Oncology 5:35 a.m. Dec. 9, 2013 - CNW Group
Update on Hospira's Investor Day - Analyst Blog 6:10 p.m. Dec. 6, 2013 - Zacks.com
Gilead Potential Blockbuster Hep C Drug Wins FDA Nod 4:22 p.m. Dec. 6, 2013 - Investors Business Daily
Pfizer - Key Reasons to Long This Biopharmaceutical Giant 3:56 p.m. Dec. 6, 2013 - GuruFocus.com
Strong Employment And Consumer Data Are Changing The Game On Wall Street 1:22 p.m. Dec. 6, 2013 - Seeking Alpha
Today's Stocks Driving Success For The Health Care Sector 12:03 p.m. Dec. 6, 2013 - TheStreet.com
4 Potential Blockbuster Drugs Awaiting Launch 5:21 p.m. Dec. 5, 2013 - Investors Business Daily
Merck & Co Inc (MRK): Today's Featured Drugs Laggard 5:03 p.m. Dec. 5, 2013 - TheStreet.com
The Deal: Merck Stakes $3 Billion on Gadget Growth 4:01 p.m. Dec. 5, 2013 - TheStreet.com
Forest Laboratories: Merck's Saphris Acquisition Is A Good Move 1:15 p.m. Dec. 5, 2013 - Seeking Alpha
The Future of Diabetes Control: Treat the Cause, Not the Symptom 9:59 a.m. Dec. 5, 2013 - Wall St. Cheat Sheet
Pharma & Biotech Stock Outlook - Dec 2013 - Industry Outlook 4:28 a.m. Dec. 3, 2013 - Zacks.com
ALK announces posting of briefing documents for FDA Advisory Committee meeting on the grass sublingual AIT tablet 8:22 a.m. Today - GlobeNewswire
Merck Advances Development Program for Investigational Alzheimer's Disease Therapy, MK-8931 7:00 a.m. Today - BusinessWire
Exostar-Powered Identity & Access Management Platform Named North America Health Care Project of the Year 9:09 a.m. Dec. 5, 2013 - BusinessWire
The Approval Of The First Biosimilar Monoclonal Antibody In Europe Has Major Implications For 2014 And Beyond 8:00 a.m. Dec. 5, 2013 - PR Newswire
Increased Quarterly Dividends, HIV Elimination Efforts, Advanced Treatment Options, and Conference Participations - Research Report on Merck, Varian, Mylan, Achillion, and Abiomed 8:00 a.m. Dec. 4, 2013 - PR Newswire
Intarcia Therapeutics Appoints Nancy Thornberry to Board of Directors 2:37 p.m. Dec. 2, 2013 - PR Newswire
Forest to Acquire U.S. Marketing Rights to Saphris(R) (asenapine) from Merck 9:00 a.m. Dec. 2, 2013 - BusinessWire
EMD Serono's New Spin-off TocopheRx to Focus on Infertility Treatment 8:30 a.m. Dec. 2, 2013 - BusinessWire
FDA Approvals, Stock Price Updates, New Study Results, Conference Schedules and Partnerships - Research Report on Merck, Pharmacyclics, UnitedHealth Group, Medtronic, and AstraZeneca 8:00 a.m. Nov. 29, 2013 - PR Newswire
Merck Announces Increased Quarterly Dividend 2:18 p.m. Nov. 26, 2013 - BusinessWire
FDA Approves Merck's NOXAFIL(R) (posaconazole) Delayed-Release Tablets 9:00 a.m. Nov. 26, 2013 - BusinessWire
Stock Price Movements and Program Launches Reported by Healthcare Companies - Research Report on Merck, Abiomed, Alere, Raptor Pharmaceuticals and West Pharmaceutical Services 8:00 a.m. Nov. 26, 2013 - PR Newswire
SiSense Wins Quarter Million Dollar Prize, Takes Top Honor in "Take the H.E.L.M." Competition 11:30 a.m. Nov. 25, 2013 - PR Newswire
Mondo Guerra and the Merck HIV Educational Campaign I Design Invite the Community to Pledge Action in Honor of World AIDS Day 8:01 a.m. Nov. 25, 2013 - PR Newswire
ARMO BioSciences Initiates Phase 1 Clinical Trial of First-In-Class Cancer Immunotherapy 8:00 a.m. Nov. 25, 2013 - PR Newswire
European Patent Office Issues Decision Regarding Universal Display's Organometallic Iridium Patent 9:01 a.m. Nov. 22, 2013 - BusinessWire
Sixth Annual Biotech Showcase(TM) Returns to San Francisco January 13-15 6:51 p.m. Nov. 21, 2013 - BusinessWire
FDA Approvals, Stock Price Movements, and Study Results - Research Report on Pfizer, Celgene, Merck, Quest Diagnostics, and Pharmacyclics 8:00 a.m. Nov. 21, 2013 - PR Newswire
Merck Consumer Health Turnaround on Track 4:00 a.m. Nov. 21, 2013 - BusinessWire
Critical Alerts For Netflix, Salesforce.com, Goldman Sachs, Merck, and Valero Energy Released By InvestorsObserver 9:31 a.m. Nov. 19, 2013 - PR Newswire
